4//SEC Filing
Kompella Uday 4
Accession 0001192482-21-000639
CIK 0001372299other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 5:28 PM ET
Size
9.5 KB
Accession
0001192482-21-000639
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Kompella Uday
Director
Transactions
- Exercise/Conversion
Common Stock
2021-07-30$1.83/sh+10,000$18,300→ 560,674 total - Exercise/Conversion
Option (right to buy)
2021-07-30−10,000→ 106,000 totalExercise: $1.83Exp: 2031-01-01→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-07-30$6.81/sh−10,000$68,072→ 550,674 total
Holdings
- 479,416(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.76 to $6.85. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The option, initially representing a right to purchase a total of 126,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on February 1, 2021, subject to continued service with the Company on the applicable vesting dates.
Documents
Issuer
Ocugen, Inc.
CIK 0001372299
Entity typeother
Related Parties
1- filerCIK 0001791821
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 5:28 PM ET
- Size
- 9.5 KB